BioAgilytix

BioAgilytix (operating at bioagilytix.com) is a global contract research organization engineered for accelerating drug development in the pharmaceutical and biotech industries. Founded by Afshin Safavi and Jim Petrilla and headquartered in Durham, North Carolina, BioAgilytix specializes in providing end-to-end bioanalytical services, eliminating the need for in-house laboratories or fragmented outsourcing. Under the hood, the company delivers precision PK (pharmacokinetics), immunogenicity, biomarker, and cell-based assays, leveraging cutting-edge technology to ensure high-quality data integrity. This allows pharmaceutical and biotech partners to streamline their drug development pipelines, reduce time-to-market, and enhance regulatory compliance. Backed by a significant investment from global investor Cinven, BioAgilytix is positioned to scale its operations and meet the growing demand for specialized bioanalytical solutions.